Found: 23
Select item for more details and to access through your institution.
Absorbed Dose-Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [<sup>177</sup>Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 6, p. 923, doi. 10.2967/jnumed.123.267023
- By:
- Publication type:
- Article
Gadolinium-Based Nanoparticles Sensitize Ovarian Peritoneal Carcinomatosis to Targeted Radionuclide Therapy.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 12, p. 1956, doi. 10.2967/jnumed.123.265418
- By:
- Publication type:
- Article
An EANM position paper on advancing radiobiology for shaping the future of nuclear medicine.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
In Silico Investigation of the Biological Implications of Complex DNA Damage with Emphasis in Cancer Radiotherapy through a Systems Biology Approach.
- Published in:
- Molecules, 2021, v. 26, n. 24, p. 7602, doi. 10.3390/molecules26247602
- By:
- Publication type:
- Article
First Symposium of the European Working Group on the Radiobiology of Molecular Radiotherapy.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 14N
- By:
- Publication type:
- Article
Targeted Radionuclide Therapy Using Auger Electron Emitters: The Quest for the Right Vector and the Right Radionuclide.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 7, p. 980, doi. 10.3390/pharmaceutics13070980
- By:
- Publication type:
- Article
Radiation-Induced Immunity and Toxicities: The Versatility of the cGAS-STING Pathway.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. N.PAG, doi. 10.3389/fimmu.2021.680503
- By:
- Publication type:
- Article
Comparison of commercial dosimetric software platforms in patients treated with <sup>177</sup>Lu‐DOTATATE for peptide receptor radionuclide therapy.
- Published in:
- Medical Physics, 2020, v. 47, n. 9, p. 4602, doi. 10.1002/mp.14375
- By:
- Publication type:
- Article
Call to arms: need for radiobiology in molecular radionuclide therapy.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Implementation of patient dosimetry in the clinical practice after targeted radiotherapy using [<sup>177</sup>Lu-[DOTA0, Tyr3]-octreotate.
- Published in:
- EJNMMI Research, 2018, v. 8, n. 1, p. 1, doi. 10.1186/s13550-018-0459-4
- By:
- Publication type:
- Article
Radiolabeled Antibodies Against Müllerian-Inhibiting Substance Receptor, Type II: New Tools for a Theranostic Approach in Ovarian Cancer.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 8, p. 1234, doi. 10.2967/jnumed.118.208611
- By:
- Publication type:
- Article
In myotonic dystrophy type 1 reduced FDG-uptake on FDG-PET is most severe in Brodmann area 8.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Targeted Cancer Therapy with a Novel Anti-CD37 Beta-Particle Emitting Radioimmunoconjugate for Treatment of Non-Hodgkin Lymphoma.
- Published in:
- PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0128816
- By:
- Publication type:
- Article
Evaluation of two I-radiolabeled acridine derivatives for Auger-electron radionuclide therapy of melanoma.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 4, p. 587, doi. 10.1007/s10637-014-0086-5
- By:
- Publication type:
- Article
The potential and hurdles of targeted alpha therapy - clinical trials and beyond.
- Published in:
- Frontiers in Oncology, 2014, v. 3, p. 1, doi. 10.3389/fonc.2013.00324
- By:
- Publication type:
- Article
Glucose metabolism in nine patients with probable sporadic Creutzfeldt–Jakob disease: FDG-PET study using SPM and individual patient analysis.
- Published in:
- Journal of Neurology, 2013, v. 260, n. 12, p. 3055, doi. 10.1007/s00415-013-7117-6
- By:
- Publication type:
- Article
Peptides in receptor-mediated radiotherapy: from design to the clinical application in cancers.
- Published in:
- Frontiers in Oncology, 2013, v. 3, p. 1, doi. 10.3389/fonc.2013.00247
- By:
- Publication type:
- Article
Comparison between Internalizing Anti-HER2 mAbs and Non-Internalizing Anti-CEA mAbs in Alpha-Radioimmunotherapy of Small Volume Peritoneal Carcinomatosis Using <sup>2</sup><sup>1</sup><sup>2</sup>Pb.
- Published in:
- PLoS ONE, 2013, v. 8, n. 7, p. 1, doi. 10.1371/journal.pone.0069613
- By:
- Publication type:
- Article
Improved realism of hybrid mouse models may not be sufficient to generate reference dosimetric data.
- Published in:
- Medical Physics, 2013, v. 40, n. 5, p. 052501, doi. 10.1118/1.4800801
- By:
- Publication type:
- Article
Vaccination with human anti-trastuzumab anti-idiotype scFv reverses HER2 immunological tolerance and induces tumor immunity in MMTV.f.huHER2(Fo5) mice.
- Published in:
- Breast Cancer Research, 2011, v. 13, n. 1, p. N.PAG, doi. 10.1186/bcr2826
- By:
- Publication type:
- Article
Vaccination with human anti-trastuzumab anti-idiotype scFv reverses HER2 immunological tolerance and induces tumor immunity in MMTV.f.huHER2(Fo5) mice.
- Published in:
- Breast Cancer Research, 2011, v. 13, n. 1, p. 1, doi. 10.1186/bcr2826
- By:
- Publication type:
- Article
Brief Intraperitoneal Radioimmunotherapy of Small Peritoneal Carcinomatosis Using High Activities of Noninternalizing <sup>125</sup>I-Labeled Monoclonal Antibodies.
- Published in:
- Journal of Nuclear Medicine, 2010, v. 51, n. 11, p. 1748, doi. 10.2967/jnumed.110.080226
- By:
- Publication type:
- Article
Noninternalizing Monoclonal Antibodies Are Suitable Candidates for <sup>125</sup>I Radioimmunotherapy of Small-Volume Peritoneal Carcinomatosis.
- Published in:
- Journal of Nuclear Medicine, 2009, v. 50, n. 12, p. 2033, doi. 10.2967/jnumed.109.066993
- By:
- Publication type:
- Article